SOX9 anticorps (AA 41-70)

N° du produit ABIN3032747

L’anticorps Souris Monoclonal anti-SOX9 a été validé pour WB et ELISA. Il convient pour détecter SOX9 dans des échantillons de Humain.

Aperçu rapide pour SOX9 anticorps (AA 41-70) (ABIN3032747)

Antigène: SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SOX9 est non-conjugé

Application: Western Blotting (WB), ELISA

Clone: 334CT39-1-4

Détail du produit anti-SOX9 anticorps

Épitope: AA 41-70

Réactivité croisée (Details): Expected species reactivity: Mouse, Pig

Purification: Purified

Immunogène: A portion of amino acids 41-70 from the human protein was used as the immunogen for this SOX9 antibody.

Isotype: IgM kappa

Information d'application

Indications d'application: Titration of the SOX9 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:100-1:500

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the SOX9 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Détails sur SOX9

Antigène: SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))

Autre désignation: SOX9

Sujet: The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.

UniProt: P48436

Pathways: EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development